Although further investigation of the correlation between expression in cancer cells and in the interstitium is required, our results suggested that RCAN2 is predominantly expressed at the IF and that KRAS-mutated CRC may promote tumor development due to decreased expression of RCAN2. This evidence concerns the gene KRAS and colorectal carcinoma.